Want to see AU:FRE full AI Analyst Report?
Firebrick Pharma Limited (FRE) Income Statement
Firebrick Pharma Limited Income Statement
Last quarter (Q4 2026), Firebrick Pharma Limited's total revenue was $42.76K, a decrease of 95.42% from the same quarter last year. In Q4, Firebrick Pharma Limited's net income was $-1.80M. See Firebrick Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 106.03K | $ 293.42K | $ 14.52K | $ 830.00 | $ 4.12K | |
| $ -1.04M | $ 104.82K | $ -22.78K | $ 830.00 | $ 4.12K | |
| $ 2.07M | $ 2.97M | $ 3.90M | $ 6.86M | $ 4.44M | |
| Depreciation and Amortization | $ 4.58K | $ 8.62K | $ 7.18K | $ 9.52K | $ 6.94K |
| $ -3.10M | $ -2.86M | $ -1.17M | $ -6.81M | $ -4.86M | |
| $ -3.10M | $ -2.87M | $ -3.93M | $ -6.86M | $ -3.36M | |
| $ 9.87K | $ 231.27K | $ 0.00 | $ 39.95K | $ -438.93K | |
| $ -3.09M | $ -2.63M | $ -1.18M | $ -6.82M | $ -3.80M | |
| $ -3.06M | $ -2.63M | $ -1.18M | $ -6.80M | $ -3.80M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.01 | $ -0.01 | $ -0.01 | $ -0.04 | $ -0.02 |
| Diluted EPS | $ -0.01 | $ -0.01 | $ -0.01 | $ -0.04 | $ -0.02 |
| Weighted Average Shares Outstanding | 254.35M | 210.28M | 179.02M | 170.09M | 168.84M |
| Weighted Average Shares Outstanding (Diluted) | 254.35M | 210.28M | 179.02M | 170.09M | 168.84M |
Currency in AUD